Effects of Nephrolithiasis on Serum DNase (Deoxyribonuclease I and II) Activity and E3 SUMO-Protein Ligase NSE2 (NSMCE2) in Malaysian Individuals

被引:5
作者
Yusof, Faridah [1 ]
Mehde, Atheer Awad [1 ,2 ]
Mehdi, Wesen Adel [3 ]
Raus, Raha Ahmed [1 ]
Ghazali, Hamid [4 ]
Abd Rahman, Azlina [5 ]
机构
[1] Int Islamic Univ Malaysia, Dept Biotechnol Engn, Coll Engn, Kuala Lumpur 50728, Malaysia
[2] Hlth & Med Tech Coll, Dept Med Anal, Baghdad 10047, Iraq
[3] Univ Baghdad, Dept Chem, Coll Sci Women, Baghdad 10071, Iraq
[4] Hosp Tengku Ampuan Afran, Dept Urol, Kuantan 25200, Malaysia
[5] Hosp Tengku Ampuan Afran, Dept Pathol, Kuantan 25200, Malaysia
关键词
Nephrolithiasis; DNase I; DNase II; E3 SUMO-protein ligase NSE2; NSMCE2; CHRONIC KIDNEY-DISEASE; APOPTOSIS; MARKERS; INJURY;
D O I
10.3967/bes2015.092
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Objective Nephrolithiasis is one of the most common disorders of the urinary tract. The aim of this study was to examine a possible relationship between DNase I/II activity and E3 SUMO-protein ligase NSE2 in the sera of nephrolithiasis patients to evaluate the possibility of a new bionnarker for evaluating kidney damage. Methods Sixty nephrolithiasis patients and 50 control patients were enrolled in a case-control study. Their blood urea, creatinine, protein levels and DNase I/II activity levels were measured by spectrometry. Serum NSMCE2 levels were measured by ELISA. Blood was collected from patients of the government health clinics in Kuantan-Pahang and fulfilled the inclusion criteria. Results The result indicated that mean levels of sera NSMCE2 have a significantly increase (P<0.01) in patients compared to control group. Compared with control subjects, activities and specific activities of serum DNase I and II were significantly elevated in nephrolithiasis patients (P<0.01). Conclusion This study suggests that an increase in serum concentrations of DNase I/II and E3 SUMO-protein ligase NSE2 level can be used as indicators for the diagnosis of kidney injury in patients with nephrolithiasis.
引用
收藏
页码:660 / 665
页数:6
相关论文
共 33 条
  • [1] Abe J, 2013, INT J INFLAM, V9, P53
  • [2] Targeting the PIAS1 SUMO ligase pathway to control inflammation
    Bin Liu
    Ke Shuai
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (10) : 505 - 509
  • [3] Delvin T, 1979, TXB BIOCH CLIN CORRE
  • [4] Fujihara Junko, 2007, Legal Medicine, V9, P233, DOI 10.1016/j.legalmed.2007.01.006
  • [5] Proteolytic processing of porcine deoxyribonuclease II occurs in lysosomes but is not required for enzyme activation
    Huang, Ru-Ting
    Liao, Ta-Hsiu
    Lu, Shao-Chun
    [J]. FEBS JOURNAL, 2009, 276 (07) : 1891 - 1899
  • [6] Protein modification by SUMO
    Johnson, ES
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 : 355 - 382
  • [7] Khan SR, 1999, J AM SOC NEPHROL, V10, pS457
  • [9] Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation
    Le, Nhat-Tu
    Corsetti, James P.
    Dehoff-Sparks, Janet L.
    Sparks, Charles E.
    Fujiwara, Keigi
    Abe, Jun-ichi
    [J]. INTERNATIONAL JOURNAL OF INFLAMMATION, 2012, 2012
  • [10] Litwin M, 2012, UROLOGIC DIS AM